Intra-articular sodium hyaluronate injection for osteoarthritis treatment. Improves joint lubrication, reduces inflammation, and promotes tissue regeneration in arthritic joints.
Manufactured by
China
Founded in 1995, Zhejiang Jingjia is a National High-Tech Enterprise and a leader in Class III medical devices. We are the first Chinese company to secure CE certification for implantable Sodium Hyaluronate Gel. Certifications: CE, ISO 13485, ISO 9001, and MDSAP. Product Range: Anti-adhesion gels, OVDs, Intra-articular injections (CE), and Dermal fillers. Global Presence: 20+ years of OEM expertise for EU and Asian markets, exported to 30+ countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hebei Houde Hanfang Medical Devices Group Co., Ltd.
China · 2 relevant products
Biosan Biyoteknoloji San ve Dış Tic A.Ş
Türkiye · 2 relevant products
Futerman International Products Laboratory
Argentina · 3 relevant products
22 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 50 closest product alternatives
Hebei Houde Hanfang Medical Devices Group Co., Ltd. · China
Therapeutic patch formulated for arthritis pain management and joint inflammation reduction. Applied topically for sustained therapeutic delivery to affected areas.
Biosan Biyoteknoloji San ve Dış Tic A.Ş · Türkiye
Pre-filled injection device delivering highly purified hyaluronic acid for intra-articular administration in joint disorders, particularly knee osteoarthritis. Each injection provides therapeutic hyaluronic acid composed of D-glucuronic acid and N-acetyl glucosamine disaccharide units to address cartilage degeneration and joint inflammation.
Futerman International Products Laboratory · Argentina
Cross-linked hyaluronic acid formulations for intra-articular injection in joint treatment and osteoarthritis management. Provides viscosupplementation and lubrication for damaged joints.
47 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products